Rabies re-examined

被引:432
作者
Rupprecht, CE
Hanlon, CA
Hemachudha, T
机构
[1] Ctr Dis Control & Prevent, Rabies Sect, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, WHO, Collaborating Ctr Reference & Res Rabies, Atlanta, GA 30333 USA
[3] Chulalongkorn Univ, Bangkok, Thailand
关键词
D O I
10.1016/S1473-3099(02)00287-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Rabies is an acute, progressive, incurable viral encephalitis. The causative agents are neurotropic RNA viruses in the family Rhabdoviridae, genus Lyssavirus. Mammalian reservoirs include the Carnivora and Chiroptera, but rabid dogs still pose the greatest hazard worldwide. Viral transmission occurs mainly via animal bite, and once the virus is deposited in peripheral wounds, centripetal passage occurs towards the central nervous system. After viral replication, there is centrifugal spread to major exit portals, the salivary glands. The epidemiological significance of any host "carrier" state remains highly speculative. Although incubation periods average 1-3 months, disease occurrence days or years after exposure has been documented. Rabies should be suspected in patients with a concomitant history of animal bite and traditional clinical presentation, but a lack of such clues makes antemortem diagnosis a challenge. Pathogenetic mechanisms remain poorly understood, and current care entails palliative measures only. Current medical emphasis relies heavily on prevention of exposure and intervention before clinical onset. Prophylaxis encompasses thorough wound treatment, vaccine administration, and inoculation of rabies immunoglobulin. Although it is a major zoonosis, canine rabies can be eliminated, and application of new vaccine technologies permits significant disease control among wildlife species. Nevertheless, despite much technical progress in the past century, rabies is a disease of neglect and presents a modern public-health conundrum.
引用
收藏
页码:327 / 343
页数:17
相关论文
共 96 条
[61]   Polymerase chain reaction protocols for rabies virus discrimination [J].
Nadin-Davis, SA .
JOURNAL OF VIROLOGICAL METHODS, 1998, 75 (01) :1-8
[62]   Antigenic and genetic divergence of rabies viruses from bat species indigenous to Canada [J].
Nadin-Davis, SA ;
Huang, W ;
Armstrong, J ;
Casey, GA ;
Bahloul, C ;
Tordo, N ;
Wandeler, AI .
VIRUS RESEARCH, 2001, 74 (1-2) :139-156
[63]  
NIEZGODA M, IN PRESS RABIES
[64]   Epidemiology of human rabies in the United States, 1980 to 1996 [J].
Noah, DL ;
Drenzek, CL ;
Smith, JS ;
Krebs, JW ;
Orciari, L ;
Shaddock, J ;
Sanderlin, D ;
Whitfield, S ;
Fekadu, M ;
Olson, JG ;
Rupprecht, CE ;
Childs, JE .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) :922-930
[65]   Risk for rabies transmission from encounters with bats, Colorado, 1977-1996 [J].
Pape, WJ ;
Fitzsimmons, TD ;
Hoffman, RE .
EMERGING INFECTIOUS DISEASES, 1999, 5 (03) :433-437
[66]  
Perera M. A. L. R., 2000, Ceylon Medical Journal, V45, P61
[67]   Molecular basis for the interaction between rabies virus phosphoprotein P and the dynein light chain LC8: dissociation of dynein-binding properties and transcriptional functionality of P [J].
Poisson, N ;
Real, E ;
Gaudin, Y ;
Vaney, MC ;
King, S ;
Jacob, Y ;
Tordo, N ;
Blondel, D .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :2691-2696
[68]   Overexpression of cytochrome c by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity [J].
Pulmanausarakul, R ;
Faber, M ;
Morimoto, K ;
Spitsin, S ;
Weihe, E ;
Hooper, DC ;
Schnell, MJ ;
Dietzschold, B .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10800-10807
[69]   Clinically silent rabies infection in (zoo) bats [J].
Ronsholt, L ;
Sorensen, KJ ;
Bruschke, CJM ;
Wellenberg, GJ ;
van Oirschot, JT ;
Johnstone, P ;
Whitby, JE ;
Bourhy, H .
VETERINARY RECORD, 1998, 142 (19) :519-520
[70]   Brief report: Human infection due to recombinant vaccinia-rabies glycoprotein virus [J].
Rupprecht, CE ;
Blass, L ;
Smith, K ;
Orciari, LA ;
Niezgoda, M ;
Whitfield, SG ;
Gibbons, RV ;
Guerra, M ;
Hanlon, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (08) :582-586